Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03930238 · ClinicalTrials.gov registry record · NA
Increasing Steps Per Day in Rural Veterans
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
NCT03930238: Completed NA study, sponsored by University of Iowa.
NCT03930238 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 276 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03930238, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
Study Summary
VA MapTrek is a mobile-phone-based web application that allows participants to take a virtual walk in interesting locations around the world while tracking their progress against the progress of other veterans on an interactive map. Steps are counted using a commercially-available triaxial accelerometer (e.g., Fitbit), and users see their progress overlaid on Google Maps. The objective of this study is to report activity levels to veterans, thereby encouraging them to walk more. Once participants know how to text and use Google maps, no additional training is needed. VA MapTrek does not require a special app, so there are no logins or passwords to remember. Simply registering one's Fitbit and mobile phone at an initial enrollment meeting suffices.
Primary Outcome
The Fitbit will provide the total number of steps that each Veteran has taken per day.
Interventions
- BEHAVIORAL Fitbit Only
- BEHAVIORAL VA MapTrek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2020-05-10 |
| Phase | NA |
What the finished NCT03930238 record still lists
NCT03930238 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Fitbit Only is the first listed.
NCT03930238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03930238 about?
NCT03930238 is a clinical study titled "Increasing Steps Per Day in Rural Veterans". VA MapTrek is a mobile-phone-based web application that allows participants to take a virtual walk in interesting locations around the world while tracking their progress against the progress of other veterans on an interactive map. Steps are counted using a commercially-available triaxial accelerom...
What is the current status of trial NCT03930238?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2019-05-15. Estimated completion is 2020-05-10.
What interventions are being tested in trial NCT03930238?
The interventions under investigation include: Fitbit Only (BEHAVIORAL), VA MapTrek (BEHAVIORAL).
Who is sponsoring clinical trial NCT03930238?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03930238's enrollment target sits among peer trials
276 383rd of 2000 higher than 1,618 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI